The role of Nuclear Factor-kappa B signaling in human cervical cancer
Sam Tilborghs(Antwerp University Hospital), Peter A. van Dam(University of Antwerp), Jérôme Corthouts(Antwerp University Hospital), Yannick Verhoeven(Antwerp University Hospital), Christian Rolfo(Icahn School of Medicine at Mount Sinai), Xuan Bich Trinh(University of Antwerp)
Cited by 273
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642